Normal screening mammogram within 90 days prior to enrollment. Bi-Rads of 1 or 2.
Dense breasts, either:
* Class C density ("the breasts are heterogeneously dense, which may obscure small masses")
* Class D density ("the breasts are extremely dense, which lowers the sensitivity of mammography")
Assigned female at birth.
Between 40 to 74 years of age (inclusive).
Ability to understand and willingness to sign an IRB approved written informed consent document.
You may not be if
Screening mammogram with BI-Rads of 0.
Contraindication to MRI with contrast (e.g. claustrophobia, metal objects in the body, known sensitivity/allergy to gadolinium).
Prior or concurrent malignancy whose natural history has the potential to interfere with the study intervention (breast cancer or non-classic LCIS). Patients with prior or concurrent malignancy that does NOT meet that definition are eligible for this trial.
Prior MRI screening of the breast.
Known to be BRCA 1/2 positive or presence of any other known high penetrance genetic marker.
Is receiving any endocrine therapy.
Has breast implants.
Is breastfeeding.
Clareo Health | Precision Supplemental Imaging in Women With Dense Breasts
